Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Product concentration Higher concentration copper peptide products may trigger more intense purging because they accelerate turnover more dramatically
Levels of urea in the blood, a waste product from the bodys use of protein that should be eliminated by the kidneys, also dropped as did weight gain, largely from retaining urine, which also can occur with kidney disease
Patients taking other medications, especially those that also affect the central nervous system, should provide their healthcare provider with a complete list of their current medications
Beyond inducing weight loss, these treatments have demonstrated benefits on obesity-related complications, including neuropsychiatric and substance use disorders, peripheral vascular disease, arthritis, MASLD, hypertension and renal disorders, positioning them as a central focus in current obesity research [3]
5/5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg BPC-157 + 2,500 mcg TB-500 per mL 250 mcg dose (of each) = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose (of each) = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg each, or 10 doses at 500 mcg each Supplies Needed (4-Week Loading at 500 mcg/day) 3 vials BPC-157/TB-500 blend (5/5 mg each) provides 30 doses at 500 mcg, covers 28 days with margin 3 vials bacteriostatic water (30 mL each) 30 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique Standard subcutaneous injection
